Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ajay Duseja, DM
PGI Hospital, Chandigarh, India
Principal Investigator - Dharmesh Kapoor
Gleneagles Global Hospital, Hyderabad
Principal Investigator - Sandeep Nijhawan
SMS Hospital, Jaipur, India
Principal Investigator - Sandeep Singh Sidhu, DM
Dayanand Medical College and Hospital, Ludhiana, Punjab, India
Principal Investigator - Shalimar S, DM
All India Institute of Medical Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Gastroenterology, Dayanand Medical College and Hospital
Ludhiana, Punjab, India
- Post Graduate Medical Institute of Medical Education and Research
Chandigarh, India
- Department of Hepatology, Global Hospital
Hyderabad, India
- Sawai Man Singh Medical College
Jaipur, India
- All India Institute of Medical Sciences
New Delhi, India
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2017
- Primary completion
- 1 Aug 2024
- Completion
- 1 Sept 2025
- Last update posted
- 24 Aug 2025
- Registered enrollment
- 174
- Registry id
- NCT02473341
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.